Could Personalized Medicine Be Your Portfolio’s Next Big Winner? Find Out

BofA analysts review the promise and limits of AI in precision medicine, highlighting key players like Tempus, Guardant, and Exact Sciences.

Latest Ratings for EXAS

DateFirmActionFromTo Feb 2022Wells FargoMaintainsEqual-Weight Feb 2022CitigroupMaintainsNeutral Feb 2022Raymond JamesMaintainsOutperform

View More Analyst Ratings for EXAS

View the Latest Analyst Ratings

read more